Atıf İçin Kopyala
ARAS ATİK E., TECEN YÜCEL K., EKİNCİOĞLU A., GÜLLÜ İ.
CLINICAL AND EXPERIMENTAL HEALTH SCIENCES, cilt.9, sa.2, ss.178-191, 2019 (ESCI)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
9
Sayı:
2
-
Basım Tarihi:
2019
-
Doi Numarası:
10.33808/clinexphealthsci.469538
-
Dergi Adı:
CLINICAL AND EXPERIMENTAL HEALTH SCIENCES
-
Derginin Tarandığı İndeksler:
Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
-
Sayfa Sayıları:
ss.178-191
-
Anahtar Kelimeler:
Capecitabine, hand-foot syndrome, mechanism, case reports, PALMAR-PLANTAR ERYTHRODYSESTHESIA, METASTATIC BREAST-CANCER, SQUAMOUS-CELL CARCINOMA, SKIN REACTION, ORAL CAPECITABINE, CLINICAL PRESENTATION, COMPLETE RESPONSE, LIVER METASTASES, LUNG METASTASES, TOPICAL HENNA
-
Anadolu Üniversitesi Adresli:
Evet
Özet
Objective: Capecitabine, a prodrug of 5-fluorouracil, is currently used in the treatment of metastatic colorectal and breast cancers. The aim of this study was to review the pharmacological mechanisms, treatment strategies, and documented case reports of capecitabine-induced hand-foot syndrome (HFS).